Endo Pharmaceuticals Inc.
Nancy J. Wysenski was appointed Chief Operating Officer on September 6, 2007. Nancy, a 20-year pharmaceutical industry veteran, most recently was the President and CEO of EMD Pharmaceuticals, Inc., the U.S. subsidiary of Germany-based Merck KGaA. Prior to joining and co-founding EMD, Nancy was the Senior Vice President of Operations at NetGenics, a start-up company specializing in sequencing software for use in drug discovery. Earlier, Nancy held a number of positions of increasing scope and responsibility at Astra Merck, where she rose to Vice President of Sales. During her tenure at Astra Merck, she also served on the company’s operating board. Nancy began her pharmaceutical industry career in 1984 at Merck Human Health as a sales representative following a successful career in nursing.
